Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iovance Biotherapeutics Inc (NQ: IOVA ) 11.86 -0.01 (-0.13%) Streaming Delayed Price Updated: 1:08 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iovance Biotherapeutics Inc < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > How to Trade Stocks Online the Right Way June 13, 2023 Learning how active trading works requires serious education, including learning how to get started. Learn how to trade stocks online on MarketBeat. Via MarketBeat Iovance Biotherapeutics to Present at Jefferies Global Healthcare Conference June 09, 2023 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2 June 02, 2023 Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics. Via Talk Markets Why Shares of Iovance Biotherapeutics Jumped Tuesday May 30, 2023 The company received approval for a biologics license application for an advanced melanoma therapy. Via The Motley Fool Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application May 30, 2023 Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Admin Via MarketBeat Topics Death Exposures Death Product Safety Analyst Expectations for Iovance Biotherapeutics's Future May 30, 2023 Via Benzinga What's Going On With Iovance Biotherapeutics Stock? May 30, 2023 Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading higher Tuesday after the U.S. Via Benzinga Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 30, 2023 Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 30, 2023 Via Benzinga Where Iovance Biotherapeutics Stands With Analysts May 30, 2023 Via Benzinga Analyst Ratings for Iovance Biotherapeutics May 10, 2023 Via Benzinga Recap: Iovance Biotherapeutics Q1 Earnings May 09, 2023 Via Benzinga Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon April 20, 2023 These two biotech stocks might be significantly undervalued. Via The Motley Fool Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket May 30, 2023 Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter... Via Benzinga Gaotu Techedu, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session May 30, 2023 U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Gaotu Techedu Inc. (NYSE: GOTU) shares jumped 19.7% to $2.98 in pre-market... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session May 29, 2023 Via Benzinga Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma May 26, 2023 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Analyst Expectations for Iovance Biotherapeutics's Future March 27, 2023 Via Benzinga Expert Ratings for Iovance Biotherapeutics March 06, 2023 Via Benzinga Ulta Beauty, Tilray Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session May 26, 2023 U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Iovance Biotherapeutics Reports First Quarter 2023 Financial Results and Corporate Updates May 09, 2023 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Iovance Biotherapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, May 9, 2023 May 02, 2023 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Why Shares of Iovance Biotherapeutics Jumped Monday May 01, 2023 The stock bounced back big from its 52-week low last week. Via The Motley Fool Iovance Biotherapeutics to Present at Upcoming Conferences April 24, 2023 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Why Shares of Iovance Biotherapeutics Jumped Monday March 27, 2023 The company filed a Biologics License Application to the FDA for its lead therapy. Via The Motley Fool Why Iovance Biotherapeutics Shares Are Trading Higher Today March 27, 2023 Iovance Biotherapeutics (NASDAQ: IOVA) shares are trading higher on Monday after the company completed its Biologics License Application submission for lifileucel. Via Benzinga Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 27, 2023 Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. Via Benzinga Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket March 27, 2023 Gainers Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) shares rose 38.5% to $2.05 in pre-market trading after gaining 8% on Friday. Via Benzinga First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session March 27, 2023 U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Iovance Biotherapeutics Completes Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma March 24, 2023 First TIL Therapy BLA Submission to U.S. Food and Drug Administration From Iovance Biotherapeutics, Inc. Via GlobeNewswire < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.